The Swiss pharmaceutical industry should be less dependent on active ingredients from Asia, says the president of the Swiss pharmacists association, pharmaSuisse. Martine Ruggli has called for new drug companies to be built in Europe.
This content was published on
1 minute
Keystone-SDA/ts
Español
es
La industria farmacéutica suiza quiere reducir su dependencia de Asia
If a drug runs out in Switzerland, it’s not available in the whole of Europe “in an extreme situation like the present one”, she said. With Europe, Switzerland must now prepare for the future, Ruggli said in an interviewExternal link with newspaper Blick on Monday.
She pointed out that the only European company for antibiotics, for example, is in Austria. Building up new locations would take time, she said, but was possible. “Sources need to be diversified.”
Enea Martinelli, a hospital pharmacist and pharmaSuisse board member, said in November that the biggest problem was children’s medications, especially fever-reducing syrup, as well as blood pressure medications, psychiatric medications and Parkinson’s medications. Painkillers are also a problem.
More
More
Swiss pharmacists warn of medicine shortages
This content was published on
Switzerland is experiencing medicine shortages due to supply chain issues linked to Covid lockdowns in China and the Ukraine war.
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
This content was published on
The parents of the young jihadist who left for Syria to join the Islamic State have been given suspended sentences by the Federal Criminal Court.
This content was published on
Felix Lehner, Pamela Rosenkranz and Miroslav Sik have been awarded the Swiss Grand Award for Art/Prix Meret Oppenheim 2025.
Nearly 2% of new Swiss disability insurance claims involve Long Covid
This content was published on
Just under 2% of new claims submitted to the disability insurance between 2021 and 2023 concern people suffering from Long Covid.
This content was published on
The watch industry had to contend with a weakening of its exports last year, which reached a volume of CHF25.9 billion ($28.5 billion).
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
The end of affordable medicine
This content was published on
Pharma companies are close to a cure for cancer, but will the hefty price tags make treatments unaffordable for most of the world?
Limited number of drugs account for a fifth of all costs
This content was published on
A lack of transparency around the pricing of many top-selling Swiss drugs is also a problem, said an umbrella group of health insurers on Wednesday.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.